Financials
- Market Capitalization 274.63 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3.82
売上高対価格比率
43.33
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3398 | NAGE Niagen Bioscience, Inc. - Common Stock | 3.53 USD | +7.29% | +3.52% | +0.28% | -29.12% | 281.14 M USD | ||
| 3405 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.62 USD | +0.56% | -6.70% | -7.18% | +29.29% | 276.80 M USD | ||
| 3420 | ALXO ALX Oncology Holdings Inc. - Common Stock | 2.01 USD | +0.50% | -14.47% | +26.42% | +327.66% | 270.47 M USD | ||
| 3422 | MGNX MacroGenics, Inc. - Common Stock | 4.25 USD | -0.93% | -8.21% | +2.41% | +183.33% | 270.14 M USD |